✦ LIBER ✦

BCG-induced mucosal immune responses

✍ Scribed by Marina Gheorghiu

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 635 KB
Volume: 16
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(94)90033-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intranasal immunization with liposomes i

Intranasal immunization with liposomes induces strong mucosal immune responses in mice

✍ Jim Vadolas; John K. Davies; Peter J. Wright; Richard A. Strugnell 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

Systemic immune responses induced by muc

Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant

✍ Lbachir BenMohamed; Yasmine Belkaid; Estelle Loing; Karima Brahimi; Helene Gras- 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

We recently reported that parenteral injection of malaria palmitoyl-tailed peptides without adjuvant efficiently induces B, Th and CTL responses. We now show that intranasal (IN) or sub-lingual (SL) delivery of such lipopeptides induces strong systemic immune responses, as demonstrated by specific T

BCG and the specific immune response to

BCG and the specific immune response to tumor

✍ I. B. Parr 📂 Article 📅 1976 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

ICOS+ Th cells produce distinct cytokine

ICOS+ Th cells produce distinct cytokines in different mucosal immune responses

✍ Kerstin Bonhagen; Oliver Liesenfeld; Miguel J. Stadecker; Andreas Hutloff; Klaus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

## Abstract T cell activation, differentiation and effector functions depend on signals delivered through the antigen‐specific TCR and non‐clonal costimulatory receptors on the T cell. Activated T cells express the inducible costimulator (ICOS). We examined the co‐expression of ICOS with Th cytokin

Enhancement of systemic and mucosal immu

Enhancement of systemic and mucosal immune responses following oral administration of liposomes

✍ Yoshimine Fujii; Yukihiko Aramaki; Toshifumi Hara; Kiyoto Yachi; Hiroshi Kikuchi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 333 KB

BCG immunotherapy of bladder cancer: Inh

BCG immunotherapy of bladder cancer: Inhibition of tumor recurrence and associated immune responses

✍ Donald L. Lamm; Daniel E. Thor; Wendell D. Winters; Valerie D. Stogdill; Howard 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Fifty-one patients with confirmed bladder cancer have enrolled in a prospective evaluation of BCG immunotherapy. Following resection of existing tumors, patients were stratified according to tumor grade and number of previous recurrences and randomly assigned to control or BCG treatment groups. Immu